Healthcare

Trough/Inflection Point. After a period of underperformance (0% average shareholder return from 2021–2025), the sector is showing signals of a "Q4 2025 rebound." "Breakthroughs at Scale." The industry is pivoting from "medicine makers" to "lifespan partners." To combat a $275 billion revenue risk fr...

Structural Contraction / Regulatory Reset. The "Golden Age" of Medicare Advantage (MA) is officially over. Following the January 2026 release of the CMS Advance Notice proposing a distinctively low 0.09% rate hike for 2027, the Managed Care Organization (MCO) sector is undergoing a painful repricing...

Aggressive Expansion / M&A Supercycle. The industry has exited the post-pandemic "recalibration" phase and is now in a high-velocity deal-making mode, with 2025 deal value hitting a decade-high ($97.6B). "Precision Portfolio Construction." Companies are shedding low-growth assets (e.g., Baxter/Vanti...